From “ACAN” to “I CAN”: Restoring wellness in a boy with severe osteochondritis dissecans through diagnostic precision combined with optimal medical, surgical and rehabilitation management

Osteochondritis dissecans (OCD) is a disease of the joints characterized by idiopathic focal subchondral lesions. Aggrecan, a proteoglycan encoded by the ACAN gene, is important for cartilage structure and function. We describe the clinical evolution of a patient with short stature, multi-focal OCD, and subchondral osteopenia that appeared linked to a novel pathogenic ACAN variant. A multi-disciplinary approach including medical (bisphosphonate) therapy, surgical intervention and rehabilitation were successful in restoring wellness and physical function.

Lead Researchers

Link to Publication

Researchers

  1. Sasha Carsen

    Scientist, CHEO Research Institute

    View Profile Email
  2. Leanne Ward

    Senior Scientist, CHEO Research Institute

    View Profile Email
  3. Marie-Eve Robinson

    Investigator, CHEO Research Institute

    View Profile Email